Notably, p-tau/Aβ42 (sensitivity of 88% and specificity of 100%) was a good discriminator of autopsy-confirmed Alzheimer’s disease from other dementia syndromes [36] (Table 1). This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.